| MLEC | Moolec Science SA | 0.01 | -99.81% |
| LSB | LakeShore Biopharma Co Ltd | 0.02 | -99.53% |
| ENVB | Enveric Biosciences Inc | 0.08 | -98.35% |
| KPRX | Kiora Pharmaceuticals Inc | 0.14 | -96.99% |
| JAGX | Jaguar Health Inc | 0.30 | -93.65% |
| LITS | Lite Strategy Inc | 0.31 | -93.47% |
| HRTX | Heron Therapeutics Inc | 0.51 | -89.40% |
| AFMD | Affimed N.V. | 0.53 | -88.98% |
| FTRE | Fortrea Holdings Inc | 0.57 | -88.08% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.58 | -87.98% |
| ENSC | Ensysce Biosciences Inc | 0.61 | -87.25% |
| CLSD | Clearside Biomedical, Inc. Common Stock | 0.64 | -86.54% |
| ONCT | Oncternal Therapeutics Inc | 0.72 | -84.94% |
| SRPT | Sarepta Therapeutics Inc | 0.73 | -84.70% |
| CELU | Celularity Inc - Class A | 0.85 | -82.30% |
| GOSS | Gossamer Bio Inc | 0.98 | -79.63% |
| XLO | Xilio Therapeutics Inc | 0.98 | -79.54% |
| SCNI | Scinai Immunotherapeutics Ltd | 1.00 | -79.19% |
| AGEN | Agenus Inc | 1.05 | -78.17% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 1.12 | -76.65% |
| IMRN | Immuron Ltd | 1.30 | -72.86% |
| KPTI | Karyopharm Therapeutics Inc | 1.30 | -72.80% |
| BOLT | Bolt Biotherapeutics Inc | 1.31 | -72.66% |
| HCWB | HCW Biologics Inc | 1.31 | -72.55% |
| CSBR | Champions Oncology Inc | 1.39 | -71.03% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | 1.39 | -70.88% |
| MDXG | Mimedx Group Inc | 1.42 | -70.38% |
| RVNC | Revance Therapeutics Inc | 1.48 | -69.10% |
| FBIO | Fortress Biotech Inc | 1.51 | -68.38% |
| ONCO | Onconetix Inc | 1.54 | -67.94% |
| AVIR | Atea Pharmaceuticals Inc | 1.55 | -67.58% |
| PBYI | Puma Biotechnology Inc | 1.62 | -66.18% |
| MGNX | Macrogenics Inc | 1.62 | -66.12% |
| VNDA | Vanda Pharmaceuticals Inc | 1.69 | -64.72% |
| CRMD | CorMedix Inc | 1.70 | -64.60% |
| NEUP | Neuphoria Therapeutics Inc | 1.70 | -64.49% |
| GLPG | Galapagos NV | 1.74 | -63.68% |
| ADCT | Adc Therapeutics SA | 1.77 | -63.12% |
| VERU | Veru Inc | 1.79 | -62.68% |
| SVA | Sinovac Biotech Ltd | 1.83 | -61.78% |
| NERV | Minerva Neurosciences Inc | 1.87 | -61.01% |
| RIGL | Rigel Pharmaceuticals | 1.90 | -60.42% |
| PTN | Palatin Technologies Inc | 1.96 | -59.07% |
| THTX | Theratechnologies Inc | 1.98 | -58.60% |
| MGX | Metagenomi Inc | 2.07 | -56.71% |
| PLX | Protalix BioTherapeutics Inc | 2.09 | -56.39% |
| BDTX | Black Diamond Therapeutics Inc | 2.11 | -55.91% |
| NAGE | Niagen Bioscience Inc | 2.12 | -55.77% |
| XBIO | Xenetic Biosciences Inc | 2.21 | -53.79% |
| RADX | Radiopharm Theranostics Ltd | 2.22 | -53.70% |
| HRMY | Harmony Biosciences Holdings Inc | 2.28 | -52.32% |
| SPRC | SciSparc Ltd | 2.33 | -51.32% |
| PHAR | Pharming Group N.V. | 2.36 | -50.80% |
| NVAX | Novavax Inc | 2.39 | -50.09% |
| SPRO | Spero Therapeutics Inc | 2.42 | -49.42% |
| GNFT | GENFIT S.A. American Depositary Shares | 2.44 | -49.14% |
| CRIS | Curis Inc | 2.47 | -48.50% |
| SAVA | Cassava Sciences Inc. | 2.54 | -47.04% |
| CGEN | Compugen Ltd | 2.63 | -45.10% |
| VRCA | Verrica Pharmaceuticals Inc | 2.66 | -44.52% |
| HYFT | MindWalk Holdings Corp | 2.68 | -44.10% |
| CTXR | Citius Pharmaceuticals Inc | 2.69 | -43.74% |
| APVO | Aptevo Therapeutics Inc | 2.70 | -43.56% |
| SXTP | 60 Degrees Pharmaceuticals Inc | 2.79 | -41.74% |
| AAPG | Ascentage Pharma Group International | 2.86 | -40.28% |
| CDXS | Codexis Inc | 2.88 | -39.99% |
| REVB | Revelation Biosciences Inc | 2.88 | -39.84% |
| ICCC | Immucell Corp | 2.95 | -38.36% |
| SABS | SAB Biotherapeutics Inc | 2.96 | -38.23% |
| MNKD | Mannkind Corp | 3.06 | -36.19% |
| VALN | Valneva SE | 3.11 | -35.00% |
| BCAB | BioAtla Inc | 3.20 | -33.14% |
| ARDX | Ardelyx Inc | 3.23 | -32.47% |
| JAZZ | Jazz Pharmaceuticals plc | 3.24 | -32.28% |
| BGMS | Bio Green Med Solution Inc | 3.27 | -31.64% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 3.32 | -30.66% |
| EVGN | Evogene Ltd | 3.32 | -30.62% |
| RARE | Ultragenyx Pharmaceutical Inc | 3.35 | -30.07% |
| ACAD | Acadia Pharmaceuticals Inc | 3.42 | -28.72% |
| APLM | Apollomics Inc - Class A | 3.42 | -28.51% |
| IMCR | Immunocore Holdings plc | 3.44 | -28.24% |
| PTHS | Channel Therapeutics Corporation | 3.44 | -28.19% |
| BMRN | Biomarin Pharmaceutical Inc | 3.45 | -27.94% |
| CUE | Cue Biopharma Inc | 3.58 | -25.38% |
| ARCT | Arcturus Therapeutics Holdings Inc | 3.62 | -24.39% |
| SLDB | Solid Biosciences Inc | 3.65 | -23.91% |
| GERN | Geron Corp | 3.66 | -23.52% |
| DTIL | Precision Biosciences Inc | 3.69 | -22.93% |
| IPSC | Century Therapeutics Inc | 3.72 | -22.41% |
| RGNX | Regenxbio Inc | 3.77 | -21.24% |
| ADMA | Adma Biologics Inc | 3.78 | -21.05% |
| BRNS | Barinthus Biotherapeutics Plc. | 3.80 | -20.70% |
| ATRA | Atara Biotherapeutics Inc | 3.80 | -20.60% |
| PHAT | Phathom Pharmaceuticals Inc | 3.82 | -20.22% |
| INCY | Incyte Corp | 3.85 | -19.70% |
| GMAB | Genmab | 3.85 | -19.55% |
| INVA | Innoviva Inc | 3.96 | -17.44% |
| TLX | Telix Pharmaceuticals Ltd | 3.97 | -17.21% |
| QTTB | Q32 Bio Inc | 4.06 | -15.23% |
| EVAX | Evaxion Biotech A/S | 4.20 | -12.35% |
| CLLS | Cellectis | 4.29 | -10.53% |
| ZLAB | Zai Lab Ltd | 4.31 | -9.97% |
| REGN | Regeneron Pharmaceuticals Inc | 4.33 | -9.62% |
| STRO | Sutro Biopharma Inc | 4.34 | -9.41% |
| ABUS | Arbutus Biopharma Corp | 4.34 | -9.32% |
| BCYC | Bicycle Therapeutics Plc | 4.43 | -7.51% |
| YMAB | Y-Mabs Therapeutics Inc | 4.57 | -4.61% |
| CHRS | Coherus Biosciences Inc | 4.67 | -2.48% |
| TRAW | Traws Pharma Inc | 4.70 | -1.98% |
| IVVD | Invivyd Inc | 4.75 | -0.83% |
| ONC | BeiGene Ltd | 4.77 | -0.51% |
| ENTA | Enanta Pharmaceuticals Inc | 4.77 | -0.45% |
| TARS | Tarsus Pharmaceuticals Inc | 4.93 | +2.83% |
| GYRE | Gyre Therapeutics Inc | 4.93 | +2.95% |
| ARVN | Arvinas Inc | 5.04 | +5.20% |
| ACHV | Achieve Life Sciences Inc | 5.09 | +6.25% |
| FDMT | 4D Molecular Therapeutics Inc | 5.17 | +7.92% |
| ELAB | PMGC Holdings Inc | 5.26 | +9.83% |
| CAI | Caris Life Sciences Inc - Class A | 5.35 | +11.68% |
| RNA | Atrium Therapeutics Inc | 5.51 | +15.02% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 5.58 | +16.48% |
| HALO | Halozyme Therapeutics Inc | 5.62 | +17.31% |
| EXEL | Exelixis Inc | 5.66 | +18.15% |
| LEGN | Legend Biotech Corp | 5.68 | +18.56% |
| VYGR | Voyager Therapeutics Inc | 5.74 | +19.82% |
| KROS | Keros Therapeutics Inc | 5.92 | +23.57% |
| FENC | Fennec Pharmaceuticals Inc | 5.93 | +23.78% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 6.02 | +25.57% |
| IOVA | Iovance Biotherapeutics Inc | 6.03 | +25.87% |
| SCPH | scPharmaceuticals Inc | 6.10 | +27.24% |
| SEER | Seer Inc - Class A | 6.13 | +27.96% |
| ASMB | Assembly Biosciences Inc | 6.37 | +32.97% |
| CPRX | Catalyst Pharmaceuticals Inc | 6.43 | +34.22% |
| DYAI | Dyadic International Inc DE | 6.46 | +34.85% |
| VCEL | Vericel Corp | 6.47 | +35.05% |
| ZVRA | Zevra Therapeutics Inc | 6.53 | +36.31% |
| IMMP | Immutep Ltd | 6.62 | +38.19% |
| ANAB | AnaptysBio Inc | 6.63 | +38.39% |
| CYCN | Cyclerion Therapeutics Inc | 6.71 | +40.06% |
| MRKR | Marker Therapeutics Inc | 6.72 | +40.27% |
| VSTM | Verastem Inc | 6.77 | +41.32% |
| ALGS | Aligos Therapeutics Inc | 6.79 | +41.73% |
| AUPH | Aurinia Pharmaceuticals Inc | 6.87 | +43.40% |
| ARQT | Arcutis Biotherapeutics Inc | 6.99 | +45.91% |
| TECH | Bio-Techne Corp | 7.04 | +46.95% |
| ZNTL | Zentalis Pharmaceuticals Inc | 7.13 | +48.83% |
| TCRX | Tscan Therapeutics Inc | 7.14 | +48.97% |
| PSTV | Plus Therapeutics Inc | 7.16 | +49.46% |
| SNDX | Syndax Pharmaceuticals Inc | 7.21 | +50.50% |
| ICU | SeaStar Medical Holding Corp | 7.32 | +52.80% |
| OBIO | Orchestra BioMed Holdings Inc | 7.36 | +53.63% |
| PTCT | PTC Therapeutics Inc | 7.39 | +54.26% |
| PYXS | Pyxis Oncology Inc | 7.57 | +58.02% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 7.58 | +58.13% |
| PRTA | Prothena Corporation plc | 7.65 | +59.69% |
| NTBL | Notable Labs Inc Ord | 7.65 | +59.69% |
| TBPH | Theravance Biopharma Inc | 7.74 | +61.56% |
| BNTX | BioNTech SE | 7.77 | +62.19% |
| FHTX | Foghorn Therapeutics Inc | 8.01 | +67.20% |
| TVTX | Travere Therapeutics Inc | 8.11 | +69.29% |
| ARTV | Artiva Biotherapeutics Inc | 8.11 | +69.29% |
| LPCN | Lipocine Inc | 8.44 | +76.18% |
| MRNA | Moderna Inc | 8.51 | +77.64% |
| XNCR | Xencor Inc | 9.05 | +88.91% |
| GOVX | Geovax Labs Inc | 9.09 | +89.74% |
| ALEC | Alector Inc | 9.16 | +91.21% |
| VRTX | Vertex Pharmaceuticals Inc | 9.26 | +93.29% |
| ALNY | Alnylam Pharmaceuticals Inc | 9.27 | +93.50% |
| SPRY | ARS Pharmaceuticals Inc | 9.29 | +93.92% |
| TGTX | TG Therapeutics Inc | 9.48 | +97.88% |
| NXTC | Nextcure Inc | 9.52 | +98.72% |
| MDGL | Madrigal Pharmaceuticals Inc | 9.68 | +102.06% |
| ACET | Adicet Bio Inc | 9.72 | +102.89% |
| SNGX | Soligenix Inc | 9.78 | +104.15% |
| URGN | UroGen Pharma Ltd | 9.78 | +104.15% |
| LENZ | LENZ Therapeutics Inc | 9.83 | +105.19% |
| MIRM | Mirum Pharmaceuticals Inc | 10.06 | +109.99% |
| HOWL | Werewolf Therapeutics Inc | 10.21 | +113.12% |
| BLRX | Bioline Rx Ltd | 10.30 | +115.00% |
| IKT | Inhibikase Therapeutics Inc | 10.39 | +116.88% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 10.41 | +117.30% |
| MGTX | MeiraGTx Holdings plc | 10.61 | +121.47% |
| CORT | Corcept Therapeutics Inc | 10.82 | +125.86% |
| XOMA | XOMA Corp | 10.84 | +126.27% |
| NUVB | Nuvation Bio Inc - Class A | 11.15 | +132.74% |
| CTNM | Contineum Therapeutics Inc - Class A | 11.15 | +132.74% |
| KURA | Kura Oncology Inc | 11.19 | +133.58% |
| ATHE | Alterity Therapeutics Ltd | 11.33 | +136.50% |
| BCDA | BioCardia Inc | 11.35 | +136.92% |
| PRQR | ProQR Therapeutics N.V | 11.36 | +137.13% |
| IDYA | Ideaya Biosciences Inc | 11.59 | +141.93% |
| CCCC | C4 Therapeutics Inc | 11.61 | +142.35% |
| ARGX | Argen X SE | 11.62 | +142.56% |
| IONS | Ionis Pharmaceuticals Inc | 11.72 | +144.64% |
| PALI | Palisade Bio Inc | 11.78 | +145.89% |
| RCUS | Arcus Biosciences Inc | 11.79 | +146.10% |
| OABI | OmniAb Inc | 11.92 | +148.82% |
| LXRX | Lexicon Pharmaceuticals Inc | 11.99 | +150.28% |
| ACOG | Alpha Cognition Inc | 12.05 | +151.53% |
| XBIT | XBiotech Inc | 12.23 | +155.29% |
| KALV | KalVista Pharmaceuticals Inc | 12.55 | +161.97% |
| MDWD | MediWound Ltd | 12.69 | +164.89% |
| CRVO | CervoMed Inc | 12.81 | +167.40% |
| SLGL | Sol-Gel Technologies Ltd | 13.01 | +171.57% |
| COYA | Coya Therapeutics Inc | 13.03 | +171.99% |
| RPRX | Royalty Pharma plc - Class A | 13.13 | +174.07% |
| SRRK | Scholar Rock Holding Corp | 13.14 | +174.28% |
| CLGN | CollPlant Biotechnologies Ltd New | 13.46 | +180.96% |
| ANL | Adlai Nortye Ltd | 13.52 | +182.30% |
| XCUR | Exicure Inc | 13.61 | +184.09% |
| EDIT | Editas Medicine Inc | 13.68 | +185.56% |
| GDTC | CytoMed Therapeutics Ltd | 14.64 | +205.59% |
| CVAC | CureVac N.V. | 14.83 | +209.56% |
| APLT | Applied Therapeutics Inc | 14.86 | +210.19% |
| CRBU | Caribou Biosciences Inc | 15.23 | +217.91% |
| ASND | Ascendis Pharma A/S | 15.38 | +221.04% |
| CANF | Can-Fite Biopharma Ltd | 15.39 | +221.25% |
| WVE | Wave Life Sciences Ltd | 15.48 | +223.13% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.61 | +246.72% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 17.76 | +270.72% |
| IMNN | Imunon Inc | 17.94 | +274.48% |
| IPHA | Innate Pharma | 18.25 | +280.95% |
| AXSM | Axsome Therapeutics Inc | 18.26 | +281.16% |
| CTMX | CytomX Therapeutics Inc | 18.28 | +281.58% |
| BEAM | Beam Therapeutics Inc | 18.35 | +283.04% |
| PRLD | Prelude Therapeutics Inc | 18.82 | +292.85% |
| SEPN | Septerna Inc | 19.01 | +296.81% |
| ABCL | AbCellera Biologics Inc | 19.62 | +309.55% |
| NRXS | Neuraxis Inc | 19.67 | +310.59% |
| LGVN | Longeveron Inc - Class A | 20.01 | +317.69% |
| EQ | Equillium Inc | 20.22 | +322.07% |
| NTRB | Nutriband Inc | 20.35 | +324.78% |
| LIXT | Lixte Biotechnology Holdings Inc | 20.35 | +324.78% |
| ZYME | Zymeworks BC Inc | 20.65 | +331.05% |
| LCTX | Lineage Cell Therapeutics Inc | 20.75 | +333.13% |
| VIR | Vir Biotechnology Inc | 21.24 | +343.36% |
| ABEO | Abeona Therapeutics Inc | 21.68 | +352.55% |
| NRIX | Nurix Therapeutics Inc | 22.04 | +360.06% |
| KRYS | Krystal Biotech Inc | 22.46 | +368.83% |
| PLUR | Pluri Inc | 22.60 | +371.75% |
| BBIO | BridgeBio Pharma Inc | 22.76 | +375.09% |
| APM | Aptorum Group Ltd - Class A | 23.35 | +387.41% |
| UNCY | Unicycive Therapeutics Inc | 23.75 | +395.76% |
| KALA | Kala Bio Inc | 23.75 | +395.76% |
| VIVS | VivoSim Labs Inc | 24.05 | +402.02% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 24.06 | +402.23% |
| VRDN | Viridian Therapeutics Inc | 24.56 | +412.66% |
| AGIO | Agios Pharmaceuticals Inc | 25.34 | +428.95% |
| NBP | NovaBridge Biosciences. | 25.39 | +429.99% |
| DARE | Dare Bioscience Inc | 25.50 | +432.29% |
| RNXT | RenovoRx Inc | 25.79 | +438.34% |
| IGC | IGC Pharma Inc | 25.79 | +438.34% |
| CGEM | Cullinan Oncology Inc | 25.86 | +439.80% |
| INSM | Insmed Inc | 26.19 | +446.69% |
| CBUS | Cibus Global Ltd. Class A | 26.70 | +457.33% |
| BRTX | BioRestorative Therapies Inc | 26.77 | +458.80% |
| IRD | Ocuphire Pharma Inc | 26.80 | +459.42% |
| SLS | SELLAS Life Sciences Group Inc | 26.90 | +461.51% |
| NTLA | Intellia Therapeutics Inc | 27.23 | +468.40% |
| ABVC | ABVC BioPharma Inc | 27.42 | +472.36% |
| VTGN | VistaGen Therapeutics Inc | 27.63 | +476.75% |
| RYTM | Rhythm Pharmaceuticals Inc | 27.90 | +482.38% |
| WHWK | Whitehawk Therapeutics Inc | 30.04 | +527.05% |
| ADAG | Adagene Inc | 30.75 | +541.87% |
| IMTX | Immatics N.V | 32.50 | +578.40% |
| GLUE | Monte Rosa Therapeutics Inc | 32.74 | +583.41% |
| RANI | Rani Therapeutics Holdings Inc Class A | 33.95 | +608.67% |
| NKTR | Nektar Therapeutics | 34.15 | +612.84% |
| MESO | Mesoblast Ltd | 34.34 | +616.81% |
| SRZN | Surrozen Inc | 34.52 | +620.57% |
| MTNB | Matinas Biopharma Holdings Inc | 34.81 | +626.62% |
| OCUL | Ocular Therapeutix Inc | 35.64 | +643.95% |
| FATE | Fate Therapeutics Inc | 36.36 | +658.98% |
| HYPD | Eyenovia Inc | 36.62 | +664.40% |
| TOVX | Theriva Biologics Inc | 37.25 | +677.55% |
| XFOR | X4 Pharmaceuticals Inc | 39.03 | +714.71% |
| KRRO | Korro Bio Inc | 39.75 | +729.74% |
| CBIO | N/A | 40.77 | +751.03% |
| KTTA | Pasithea Therapeutics Corp | 42.15 | +779.84% |
| TRDA | Entrada Therapeutics Inc | 42.62 | +789.65% |
| PGEN | Precigen Inc | 43.89 | +816.16% |
| LEXX | Lexaria Bioscience Corp | 44.19 | +822.42% |
| BYSI | BeyondSpring Inc | 45.99 | +859.99% |
| ADXN | Addex Therapeutics Ltd | 47.60 | +893.60% |
| PHIO | Phio Pharmaceuticals Corp | 48.01 | +902.16% |
| VYNE | VYNE Therapeutics Inc | 48.39 | +910.09% |
| SPRB | Spruce Biosciences Inc | 49.19 | +926.79% |
| CLDI | Calidi Biotherapeutics Inc | 50.83 | +961.02% |
| IBRX | ImmunityBio Inc | 51.86 | +982.52% |
| PPBT | Purple Biotech Ltd | 51.90 | +983.31% |
| NBTX | Nanobiotix | 52.28 | +991.29% |
| SGMT | Sagimet Biosciences Inc - Class A | 52.50 | +995.88% |
| ARMP | Armata Pharmaceuticals Inc | 53.35 | +1013.62% |
| KZIA | Kazia Therapeutics Ltd | 53.44 | +1015.52% |
| STOK | Stoke Therapeutics Inc | 55.29 | +1054.12% |
| MCRB | Seres Therapeutics Inc | 55.92 | +1067.27% |
| CAMP | CAMP4 Therapeutics Corp | 57.28 | +1095.66% |
| JANX | Janux Therapeutics Inc | 58.53 | +1121.75% |
| ONCY | Oncolytics Biotech Inc | 58.60 | +1123.21% |
| ACIU | AC Immune SA | 58.97 | +1130.94% |
| PRTC | PureTech Health plc American Depositary Shares | 59.84 | +1149.10% |
| GLMD | Galmed Pharmaceuticals Ltd | 61.38 | +1181.24% |
| OVID | Ovid Therapeutics Inc | 62.50 | +1204.62% |
| COCP | Cocrystal Pharma Inc | 62.50 | +1204.62% |
| MAZE | Maze Therapeutics Inc | 65.47 | +1266.62% |
| EPIX | Essa Pharma Inc | 65.79 | +1273.25% |
| DMAC | DiaMedica Therapeutics Inc | 66.68 | +1291.87% |
| NRXP | NRX Pharmaceuticals Inc | 70.46 | +1370.78% |
| ACRS | Aclaris Therapeutics Inc | 72.11 | +1405.22% |
| OMER | Omeros Corporation | 72.94 | +1422.54% |
| TNGX | Tango Therapeutics Inc | 73.25 | +1429.02% |
| IVA | Inventiva | 73.66 | +1437.57% |
| EVMN | Evommune Inc | 73.80 | +1440.50% |
| ALLR | Allarity Therapeutics Inc | 74.08 | +1446.34% |
| APRE | Aprea Therapeutics Inc | 74.64 | +1458.03% |
| IMA | Ikena Oncology Inc | 83.32 | +1639.22% |
| RAPP | Rapport Therapeutics Inc | 84.20 | +1657.59% |
| ORMP | Oramed Pharmaceuticals Inc | 86.55 | +1706.64% |
| CYTK | Cytokinetics Inc | 87.83 | +1733.36% |
| OGEN | Oragenics Inc | 89.28 | +1763.62% |
| OCGN | Ocugen Inc | 90.22 | +1783.25% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 91.86 | +1817.48% |
| QURE | uniQure N.V. | 92.23 | +1825.20% |
| CVM | Cel-Sci Corp | 92.88 | +1838.77% |
| ADVM | Adverum Biotechnologies Inc | 94.37 | +1869.87% |
| PTGX | Protagonist Therapeutics Inc | 95.50 | +1893.46% |
| SILO | SILO Pharma Inc | 96.26 | +1909.33% |
| AEON | AEON Biopharma Inc - Class A | 97.16 | +1928.11% |
| MREO | Mereo Biopharma Group Plc | 97.27 | +1930.41% |
| MIST | Milestone Pharmaceuticals Inc | 98.25 | +1950.86% |
| HIND | ReShape Lifesciences Inc | 99.95 | +1986.35% |
| UPB | Upstream Bio Inc | 102.88 | +2047.51% |
| RLYB | Rallybio Corp | 107.21 | +2137.89% |
| MNOV | Medicinova Inc | 107.25 | +2138.73% |
| HUMA | Humacyte Inc | 115.08 | +2302.17% |
| SKYE | Skye Bioscience Inc | 117.90 | +2361.04% |
| ZBIO | Zenas Biopharma Inc | 119.50 | +2394.44% |
| AIM | AIM ImmunoTech Inc. | 120.98 | +2425.33% |
| PRME | Prime Medicine Inc | 121.34 | +2432.84% |
| CAPR | Capricor Therapeutics Inc | 124.43 | +2497.34% |
| KYMR | Kymera Therapeutics Inc | 125.01 | +2509.45% |
| RNAC | Cartesian Therapeutics Inc | 127.79 | +2567.48% |
| EYPT | EyePoint Pharmaceuticals Inc | 135.77 | +2734.05% |
| OPT | Opthea Ltd | 151.40 | +3060.24% |
| NAMS | NewAmsterdam Pharma Company NV | 151.95 | +3071.79% |
| MOLN | Molecular Partners AG | 156.56 | +3168.02% |
| DBVT | DBV Technologies | 165.40 | +3352.55% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 169.88 | +3446.06% |
| GRDX | Entero Therapeutics Inc | 182.31 | +3705.53% |
| CRDF | Cardiff Oncology Inc | 192.74 | +3923.24% |
| LSTA | Lisata Therapeutics Inc | 193.38 | +3936.60% |
| GRCE | Acasti Pharma Inc | 197.75 | +4027.82% |
| CRNX | Crinetics Pharmaceuticals Inc | 200.27 | +4080.42% |
| SER | AgeX Therapeutics Inc | 200.74 | +4090.23% |
| GTBP | GT Biopharma Inc | 204.96 | +4178.32% |
| TSHA | Taysha Gene Therapies Inc | 207.70 | +4235.52% |
| ASBP | Aspire Biopharma Holdings Inc | 210.28 | +4289.37% |
| AZTR | Azitra Inc | 239.97 | +4909.12% |
| ATYR | Atyr Pharma Inc | 241.72 | +4945.65% |
| GANX | Gain Therapeutics Inc | 255.50 | +5233.29% |
| CMPX | Compass Therapeutics Inc | 269.28 | +5520.93% |
| RLAY | Relay Therapeutics Inc | 275.39 | +5648.47% |
| CYBN | Cybin Inc | 278.25 | +5708.17% |
| IBIO | iBio Inc | 311.32 | +6398.47% |
| STTK | Shattuck Labs Inc | 314.77 | +6470.49% |
| SLN | Silence Therapeutics Plc | 337.79 | +6951.01% |
| CDIO | Cardio Diagnostics Holdings Inc | 344.81 | +7097.54% |
| CLRB | Cellectar Biosciences Inc | 348.47 | +7173.94% |
| VRNA | Verona Pharma Plc | 350.73 | +7221.12% |
| ATNM | Actinium Pharmaceuticals Inc | 352.10 | +7249.71% |
| AUTL | Autolus Therapeutics plc | 365.22 | +7523.58% |
| ALMS | Alumis Inc | 366.45 | +7549.25% |
| ANIX | Anixa Biosciences Inc | 377.78 | +7785.76% |
| ATAI | ATAI Life Sciences N.V. | 395.29 | +8151.26% |
| OTLK | Outlook Therapeutics Inc | 396.96 | +8186.12% |
| CNTA | Centessa Pharmaceuticals plc | 409.21 | +8441.82% |
| TENX | Tenax Therapeutics Inc | 414.72 | +8556.84% |
| YDES | YD Bio Ltd | 430.93 | +8895.21% |
| CADL | Candel Therapeutics Inc | 436.42 | +9009.80% |
| NGNE | Neoleukin Therapeutics Inc | 438.73 | +9058.02% |
| JUNS | Jupiter Neurosciences Inc | 448.27 | +9257.16% |
| LXEO | Lexeo Therapeutics Inc | 478.26 | +9883.17% |
| LNAI | Lunai Bioworks Inc | 489.28 | +10113.20% |
| IMNM | Immunome Inc | 512.24 | +10592.46% |
| ABSI | Absci Corp | 532.00 | +11004.93% |
| ABOS | Acumen Pharmaceuticals Inc | 538.78 | +11146.46% |
| TVRD | Cara Therapeutics Inc | 559.61 | +11581.26% |
| IMRX | Immuneering Corp Class A | 563.62 | +11664.97% |
| CNTB | Connect Biopharma Holdings Ltd | 581.00 | +12027.76% |
| OCS | Oculis Holding AG | 590.44 | +12224.81% |
| SYRE | Spyre Therapeutics Inc | 650.22 | +13472.65% |
| TNYA | Tenaya Therapeutics Inc | 662.57 | +13730.44% |
| XENE | Xenon Pharmaceuticals Inc | 727.44 | +15084.54% |
| GRCL | Gracell Biotechnologies Inc | 732.21 | +15184.10% |
| INMB | INmune Bio Inc | 760.34 | +15771.29% |
| SNTI | Senti Biosciences Inc | 786.90 | +16325.70% |
| VRAX | Virax Biolabs Group Ltd - Class A | 793.06 | +16454.28% |
| COGT | Cogent Biosciences Inc | 861.15 | +17875.59% |
| PROK | ProKidney Corp - Class A | 876.39 | +18193.70% |
| PRAX | Praxis Precision Medicines Inc | 953.14 | +19795.78% |
| CGON | Cg Oncology Inc | 955.25 | +19839.83% |
| INBX | Inhibrx Biosciences Inc | 1009.72 | +20976.83% |
| CRSP | CRISPR Therapeutics AG | 1241.19 | +25808.52% |
| ERNA | Ernexa Therapeutics Inc | 1275.37 | +26521.99% |
| PCSA | Processa Pharmaceuticals Inc | 1320.06 | +27454.85% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1459.05 | +30356.12% |
| ENTX | Entera Bio Ltd | 1547.08 | +32193.65% |
| IBO | Impact BioMedical Inc | 1573.08 | +32736.37% |
| ABVX | Abivax | 1589.40 | +33077.03% |
| INO | Inovio Pharmaceuticals Inc | 1712.37 | +35643.90% |
| TCRT | Alaunos Therapeutics Inc | 1774.63 | +36943.51% |
| ATOS | Atossa Therapeutics Inc | 1872.06 | +38977.26% |
| MBIO | Mustang Bio Inc | 2205.73 | +45942.27% |
| PULM | Pulmatrix Inc | 2459.21 | +51233.39% |
| ROIV | Roivant Sciences Ltd | 2538.35 | +52885.35% |
| CELZ | Creative Medical Technology Holdings Inc | 2618.47 | +54557.77% |
| CLDX | Celldex Therapeutics Inc | 2685.97 | +55966.77% |
| BNTC | Benitec Biopharma Inc | 2770.13 | +57723.52% |
| PLRX | Pliant Therapeutics Inc | 3071.82 | +64020.97% |
| DNTH | Dianthus Therapeutics Inc | 3126.94 | +65171.54% |
| NTHI | NeOnc Technologies Holdings Inc | 3477.63 | +72491.83% |
| KYTX | Kyverna Therapeutics Inc | 3513.34 | +73237.23% |
| CMRX | Chimerix Inc | 3613.35 | +75324.83% |
| DNLI | Denali Therapeutics Inc | 3643.65 | +75957.32% |
| SMMT | Summit Therapeutics Inc | 3891.31 | +81126.95% |
| PMN | ProMIS Neurosciences Inc | 4016.22 | +83734.32% |
| ALXO | Alx Oncology Holdings Inc | 5085.96 | +106064.00% |
| IFRX | InflaRx N.V. | 6161.81 | +128521.23% |
| GUTS | Fractyl Health Inc | 7575.74 | +158035.51% |
| ALLO | Allogene Therapeutics Inc | 7784.36 | +162390.23% |
| LPTX | Leap Therapeutics Inc | 8475.88 | +176824.91% |
| RLMD | Relmada Therapeutics Inc | 9001.90 | +187805.08% |
| RVMD | Revolution Medicines Inc | 9035.10 | +188498.10% |
| AVTX | Avalo Therapeutics Inc | 9875.25 | +206035.33% |
| LYEL | Lyell Immunopharma Inc | 10048.71 | +209656.13% |
| ALT | Altimmune Inc | 10694.01 | +223126.08% |
| PMCB | PharmaCyte Biotech Inc | 12904.41 | +269265.82% |
| GNLX | Genelux Corp | 16030.45 | +334518.58% |
| VTVT | vTv Therapeutics Inc - Class A | 17944.71 | +374476.73% |
| DSGN | Design Therapeutics Inc | 29402.82 | +613652.57% |
| TRML | Tourmaline Bio Inc | 30893.12 | +644761.05% |
| TIL | Instil Bio Inc | 54248.82 | +1132286.38% |
| ETNB | 89bio Inc | 111568.68 | +2328777.39% |
| EDSA | Edesa Biotech Inc | 130462.29 | +2723161.45% |
| SVRA | Savara Inc | 145272.62 | +3032311.33% |
| AKTX | Akari Therapeutics Plc | 478368.50 | +9985333.32% |
| NKTX | Nkarta Inc | 1.00M | +20873835.71% |